Under the T2DM condition, the Slc2a2 mRNA and GLUT2 protein content increased by 90% and 27% (p < 0.05 vs. ND), respectively, and resveratrol treatment reversed these alterations. The gene discussed is SLC2A2; the disease is type 2 diabetes mellitus.